CHRNA9 and glioma: This analysis revealed that survival of patients with tumors overexpressing CHRNA1 or CHRNA9, which are both expressed in all our GSC lines (Supplementary Figure S2), is significantly shorter as compared to all gliomas (Supplementary Figure S3 A,B; n = 343).